References
Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr (2009) Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum 60:1112–1118
Akhmetshina A, Venalis P, Dees C, Busch N, Zwerina J, Schett G, Distler O, Distler JH (2009) Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum 60:219–224
Alonso N, Soldevila B, Sanmarti A, Pujol-Borrell R, Martinez-Caceres E (2009) Regulatory T cells in diabetes and gastritis. Autoimmun Rev 8:659–662
Amjadi S, Maranian P, Furst DE, Clements PJ, Wong WK, Postlethwaite AE, Khanna PP, Khanna D (2009) Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum 60:2490–2498
Askenasy N, Kaminitz A, Yarkoni S (2008) Mechanisms of T regulatory cell function. Autoimmun Rev 7:370–375
Beretta L, Cappiello F, Moore JH, Barili M, Greene CS, Scorza R (2008) Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum 59:974–983
Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, Leclercq S, St Pierre Y, Baron M (2009) The cost of systemic sclerosis. Arthritis Rheum 61:119–123
Bernatsky S, Hudson M, Pope J, Vinet E, Markland J, Robinson D, Jones N, Docherty P, Abu-Hakima M, Leclercq S, Dunne J, Smith D, Mathieu JP, Khalidi N, Sutton E, Baron M (2008) Assessment of reproductive history in systemic sclerosis. Arthritis Rheum 59:1661–1664
Bernatsky S, Joseph L, Pineau CA, Belisle P, Hudson M, Clarke AE (2009) Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 61:400–404
Bianco NR, Kim SH, Ruffner MA, Robbins PD (2009) Therapeutic effect of exosomes from indoleamine 2, 3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 60:380–389
Bogatkevich GS, Ludwicka-Bradley A, Silver RM (2009) Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis Rheum 60:3455–3464
Campbell IK, Kinkel SA, Drake SF, van Nieuwenhuijze A, Hubert FX, Tarlinton DM, Heath WR, Scott HS, Wicks IP (2009) Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Arthritis Rheum 60:1683–1693
Carambia A, Herkel J (2009) CD4 T cells in hepatic immune tolerance. J Autoimmun 34(1):23–28
Chang C, and Gershwin ME (2009) Drugs and autoimmunity—a contemporary review and mechanistic approach. J Autoimmun. doi:10.1016/j.jaut.2009.11.012
Chiorini JA, Cihakova D, Ouellette CE, Caturegli P (2009) Sjogren syndrome: advances in the pathogenesis from animal models. J Autoimmun 33:190–196
Christen U, Hintermann E, Holdener M, von Herrath MG (2010) Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? J Autoimmun 34(1):38–44
Chung L, Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL, Whitfield ML, Chang HY, Robinson WH (2009) Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum 60:584–591
Davies AJ (2008) Immunological tolerance and the autoimmune response. Autoimmun Rev 7:538–543
Dhirapong A, Lleo A, Leung P, Gershwin ME, Liu FT (2009) The immunological potential of galectin-1 and -3. Autoimmun Rev 8:360–363
Dieude P, Wipff J, Guedj M, Ruiz B, Melchers I, Hachulla E, Riemekasten G, Diot E, Hunzelmann N, Sibilia J, Tiev K, Mouthon L, Cracowski JL, Carpentier PH, Distler J, Amoura Z, Tarner I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore Y (2009) BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum 60:3447–3454
Distler JH, Beyer C, Schett G, Luscher TF, Gay S, Distler O (2009) Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum 60:3168–3179
Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 8:24–28
Elagin RB, Balijepalli S, Diacovo MJ, Baekkeskov S, Jaume JC (2009) Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice. J Autoimmun 33:50–57
Fiocco U, Sfriso P, Oliviero F, Pagnin E, Scagliori E, Campana C, Dainese S, Cozzi L, Punzi L (2008) Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev 8:76–82
Fuschiotti P, Medsger TA Jr, Morel PA (2009) Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum 60:1119–1128
Gleicher N, Elkayam U (2009) Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8:384–387
Gomez-Martin D, Diaz-Zamudio M, Alcocer-Varela J (2008) Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response. Autoimmun Rev 7:284–290
Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006–1019
Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, Gay RE, Pisetsky DS, Gay S, Matucci-Cerinic M, Distler O (2008) The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 58:2845–2853
Harrison LC, Honeyman MC, Morahan G, Wentworth JM, Elkassaby S, Colman PG, Fourlanos S (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310
Hasegawa M, Matsushita Y, Horikawa M, Higashi K, Tomigahara Y, Kaneko H, Shirasaki F, Fujimoto M, Takehara K, Sato S (2009) A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Arthritis Rheum 60:3465–3475
Hemminki K, Li X, Sundquist J, Sundquist K (2009) The epidemiology of Graves' disease: Evidence of a genetic and an environmental contribution. J Autoimmun (in press)
Hewagama A, Richardson B (2009) The genetics and epigenetics of autoimmune diseases. J Autoimmun 33:3–11
Hoffmann MH, Trembleau S, Muller S, Steiner G (2009) Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun
Holz LE, Warren A, Le Couteur DG, Bowen DG, Bertolino P (2010) CD8+ T cell tolerance following antigen recognition on hepatocytes. J Autoimmun 34(1):15–22
Hudson M, Rojas-Villarraga A, Coral-Alvarado P, Lopez-Guzman S, Mantilla RD, Chalem P, Baron M, Anaya JM (2008) Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 31:156–159
Hudson M, Thombs B, Baron M (2009) Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum 61:274–278
Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112–1120
Jamin C, Morva A, Lemoine S, Daridon C, de Mendoza AR, Youinou P (2008) Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum 58:1900–1906
Kabalak G, Dobberstein SB, Matthias T, Reuter S, The YH, Dorner T, Schmidt RE, Witte T (2009) Association of immunoglobulin-like transcript 6 deficiency with Sjogren's syndrome. Arthritis Rheum 60:2923–2925
Kaminitz A, Mizrahi K, Yaniv I, Farkas DL, Stein J, Askenasy N (2009) Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice. J Autoimmun 33:83–91
Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS (2009) Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 33:239–246
La Cava A (2008) Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev 8:83–87
Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel PA, Simms RW (2009) B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60:578–583
Leuschner F, Katus HA, Kaya Z (2009) Autoimmune myocarditis: past, present and future. J Autoimmun 33:282–289
Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, Utz PJ, Crabtree GR, Parnes JR (2008) Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum 58:3192–3204
Lleo A, Invernizzi P, Gao B, Podda M, and Gershwin ME (2009) Definition of human autoimmunity—autoantibodies versus autoimmune disease. Autoimmun Rev
Loizos N, Lariccia L, Weiner J, Griffith H, Boin F, Hummers L, Wigley F, Kussie P (2009) Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 60:1145–1151
Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE (2009) Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 60:569–577
Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, Guillevin L, Kahan A, Allanore Y (2008) Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 58:1803–1809
Meyer-Bahlburg A, Rawlings DJ (2008) B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev 7:313–316
Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60:2390–2401
Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ (2009) Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 33:247–254
Morris GP, Brown NK, Kong YC (2009) Naturally existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 33:68–76
Mouthon L, Rannou F, Berezne A, Pagnoux C, Guilpain P, Goldwasser F, Revel M, Guillevin L, Fermanian J, Poiraudeau S (2008) Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey. Arthritis Rheum 59:968–973
Peron JP, de Oliveira AP, Rizzo LV (2009) It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun Rev 9:1–4
Pessach IM, Notarangelo LD (2009) X-linked primary immunodeficiencies as a bridge to better understanding X chromosome-related autoimmunity. J Autoimmun 33:17–24
Picha L, Pakas I, Guialis A, Moutsopoulos HM, Vlachoyiannopoulos PG (2008) Comparative qualitative and quantitative analysis of scleroderma (systemic sclerosis) serologic immunoassays. J Autoimmun 31:166–174
Razykov I, Thombs BD, Hudson M, Bassel M, Baron M (2009) Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum 61:1765–1770
Robitaille G, Christin MS, Clement I, Senecal JL, Raymond Y (2009) Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells. Arthritis Rheum 60:2805–2816
Round JL, O'Connell RM, and Mazmanian SK (2009) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun (in press)
Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E (2009) Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 60:1743–1752
Scaglione BJ, Salerno E, Gala K, Pan M, Langer JA, Mostowski HS, Bauer S, Marti G, Li Y, Tsiagbe VK, Raveche ES (2009) Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. J Autoimmun 32:14–23
Schouffoer AA, van der Marel J, Ter Kuile MM, Weijenborg PT, Voskuyl A, Vliet Vlieland CW, van Laar JM, Vliet Vlieland TP (2009) Impaired sexual function in women with systemic sclerosis: a cross-sectional study. Arthritis Rheum 61:1601–1608
Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, Herrmann M (2008) Clearance deficiency—a potential link between infections and autoimmunity. Autoimmun Rev 8:5–8
Su TI, Khanna D, Furst DE, Danovitch G, Burger C, Maranian P, Clements PJ (2009) Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study. Arthritis Rheum 60:3821–3830
Subleski JJ, Wiltrout RH, Weiss JM (2009) Application of tissue-specific NK and NKT cell activity for tumor immunotherapy. J Autoimmun 33:275–281
Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmas P, Szamosi S, Szanto J, Kiss E (2008) Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. J Autoimmun 31:372–376
Tiegs G, Lohse AW (2010) Immune tolerance: What is unique about the liver. J Autoimmun 34(1):1–6
Villela R, Yuen SY, Pope JE, Baron M (2008) Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment. Arthritis Rheum 59:706–713
Waldner H (2009) The role of innate immune responses in autoimmune disease development. Autoimmun Rev 8:400–404
Yaniv I, Ash S, Farkas DL, Askenasy N, Stein J (2009) Consideration of strategies for hematopoietic cell transplantation. J Autoimmun 33:255–259
Youinou P, Jamin C (2009) The weight of interleukin-6 in B cell-related autoimmune disorders. J Autoimmun 32:206–210
Zhang J, Jacobi AM, Wang T, Berlin R, Volpe BT, Diamond B (2009) Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun 33:270–274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guillevin, L. A Contemporary Update on Scleroderma. Clinic Rev Allerg Immunol 40, 75–77 (2011). https://doi.org/10.1007/s12016-010-8200-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-010-8200-8